Group One Trading
HBIO icon

Group One Trading’s Harvard Bioscience HBIO Stock Holding History

Group One Trading’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112K Buy
23,100
+18,550
+408% +$104K ﹤0.01% 4622
2025
Q4 		$30.4K Buy
4,550
+3,220
+242% +$19.1K ﹤0.01% 6013
2025
Q3 		$5.83K Sell
1,330
-1,730
-57% -$8.21K ﹤0.01% 7464
2025
Q2 		$13.6K Buy
3,060
+2,960
+2,960% +$12.4K ﹤0.01% 6529
2025
Q1 		$566 Hold
100
– – ﹤0.01% 7265
2024
Q4 		$2.11K Buy
+100
New +$2.3K ﹤0.01% 6718
2024
Q3 		– Sell
-1,000
Closed -$28.5K – 6912
2024
Q2 		$28.5K Buy
1,000
+960
+2,400% +$33.7K ﹤0.01% 4961
2024
Q1 		$1.7K Buy
+40
New +$1.8K ﹤0.01% 6523
2023
Q4 		– Sell
-30
Closed -$1.29K – 7693
2023
Q3 		$1.29K Sell
30
-90
-75% -$4.15K ﹤0.01% 7165
2023
Q2 		$6.59K Buy
+120
New +$6.58K ﹤0.01% 6590
2022
Q2 		– Sell
-10
Closed -$1K – 8082
2022
Q1 		$1K Hold
10
– – ﹤0.01% 7834
2021
Q4 		$1K Hold
10
– – ﹤0.01% 7988
2021
Q3 		$1K Buy
+10
New +$796 ﹤0.01% 8014
2015
Q2 		– Sell
-120
Closed -$7K – 4968
2015
Q1 		$7K Sell
120
-1,140
-90% -$61.2K ﹤0.01% 4258
2014
Q4 		$71K Buy
1,260
+90
+8% +$4.29K ﹤0.01% 3112
2014
Q3 		$48K Hold
1,170
– – ﹤0.01% 3545
2014
Q2 		$53K Buy
1,170
+770
+193% +$32.4K ﹤0.01% 3498
2014
Q1 		$19K Buy
400
+300
+300% +$13.7K ﹤0.01% 4270
2013
Q4 		$5K Sell
100
-177
-64% -$7.73K ﹤0.01% 4842
2013
Q3 		$11K Buy
277
+79
+40% +$3.11K ﹤0.01% 4451
2013
Q2 		$7K Buy
+198
New +$7.58K ﹤0.01% 4569

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's HBIO Position: Q1 2026 in Review

Group One Trading reduced its Harvard Bioscience (HBIO) stake by 14% in Q1 2026, selling an estimated $2.06K and leaving 2,182 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6346.

Group One Trading first reported a position in HBIO in Q2 2013 and has held it in 13 quarters since. The position peaked at $430K in Q3 2013. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Group One Trading held 2,182 shares of Harvard Bioscience worth $10.6K as of Q1 2026.
  • Group One Trading sold 369 Harvard Bioscience shares in Q1 2026, an estimated $2.06K.
  • Harvard Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6346 holding.
  • Group One Trading first reported a position in Harvard Bioscience in Q2 2013 and has held it in 13 quarters since.
  • Group One Trading's Harvard Bioscience position peaked at $430K in Q3 2013.
  • 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.